The global artificial organs and bionic implants market revenue was around US$ 44.4 billion in 2022 and is estimated to reach US$ 86.5 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.7% during the forecast period from 2023 to 2031.
Artificial organs and bionic implants are medical devices designed to supplement or replace the function of natural organs or body components that are absent, injured, or defective. These devices use cutting-edge technology and engineering principles to improve quality of life, restore or increase physiological functions, and offer therapeutic advantages to people with mental disabilities and conditions.
Market Driving Factors
An increase in the prevalence of vision impairment is fueling the market expansion. For instance, the World Health Organisation (WHO) reports that roughly 2.2 billion people worldwide suffer from a near- or distance-vision impairment, with about 1 billion of these instances being unaddressed. Additionally, according to the same source, 8 million people around the world have age-related macular degeneration. Thus, the increase in the prevalence of age-related retinitis pigmentosa and macular degeneration has resulted in a surge in demand for artificial organs and bionic implants market.
Advancements in medical technology have led to the development of more sophisticated and efficient bionic implants and artificial organs. Enhanced materials, wireless connectivity, miniaturization, and cutting-edge sensors have improved the functionality and performance of these devices, which fuels the market expansion.
The high price of implant procedures and the scarcity of surgeons hinder market growth.
Regional Analysis
North America dominated the market and is estimated to continue its dominance over the forecast period. This can be attributed to the presence of several significant players, including Boston Scientific Corporation, Jarvik Heart, Inc., and SynCardia Systems, LLC. An increase in the number of clinical trials, the accessibility of cutting-edge healthcare facilities, and high government spending on healthcare in this region drive the market expansion. Additionally, the U.S. is predicted to be a major share in the region. This is due to the existence of important players, the prevalence of heart disease patients, high purchasing power, the increase in the use of items including bionic implants and artificial organs, and a sizable increase in capital income in industrialized nations.
Asia-Pacific is estimated to increase at the highest rate over the projection period. This is due to an increase in road accidents and injuries and a surge in the purchasing power of populous nations like India and China. The countries in the region as a whole are enormous, with India having the most people (1.48 billion population) and China having the second-highest (1.41 billion population). As a result, an increase in population and an increase in life expectancy is estimated to fuel the market growth in the region.
Segmentation Insights
Technology Insight
The mechanical segment dominated the market in terms of shares. This can be attributed to the surge in the incidence of organ failure and the low price of mechanical bionics. A mechanical artificial heart valve lasts much longer as compared to the other options, making a robust demand. Furthermore, rapid FDA approvals and reimbursement regulations are other elements influencing the increase. For instance, the FDA authorized Abbott's Portico with the FlexNav TAVR system to treat patients with symptomatic and aortic stenosis who may be at very high risk for open-heart surgery.
The electronic segment is estimated to dominate the market in terms of revenue. According to Bionics Queensland, approximately 1.0 billion people live with a physical handicap, and 190.0 million adults experience primary functional difficulty. The logistical and budgetary obstacles are still significant in the majority of developing nations. The only option for many who are disabled is to get prosthetics like artificial arms, hands, and legs. These prosthetics are electronic systems and batteries that are myoelectric-controlled and can produce nerve movement through sensors. These sensory electric technologies allow mobility in artificial organs. Smart wearables, machine learning, and element models are utilized to achieve mobility. In addition, the surge number of road accidents, the increasing prevalence of amputees, and individuals born without limbs are estimated to create a demand for the segment.
Prominent Companies
Segmentation Outline
The global artificial organs and bionic implants market segmentation focuses on Type, Technology, End User, and Region.
By Type
By Technology
By End User
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE
5.1 OVERVIEW
5.2 EAR BIONICS
5.3 ORTHOPEDIC BIONICS
5.3.1 BIONIC HAND
5.3.2 BIONIC LEG
5.3.3 OTHERS
5.4 OTHERS
6 GLOBAL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 ELECTRONIC
6.3 MECHANICAL
7 GLOBAL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER
7.1 OVERVIEW
7.2 HOSPITALS
7.3 AMBULATORY SURGICAL CENTERS
7.4 OTHERS
8 GLOBAL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 JARVIK HEART, INC
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 JOHNSON & JOHNSON
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 BOSTON SCIENTIFIC CORPORATION
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 COCHLEAR LIMITED
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 ABBOTT LABORATORIES
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 SYNCARDIA SYSTEMS LLC
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 EDWARDS LIFESCIENCES CORPORATION MEDTRONIC PLC
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 ZIMMER BIOMET HOLDING INC
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 BERLIN HEART GMBH
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved